Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 692-793-0 | CAS number: 156487-12-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Mar 06 - Jun 29, 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- The information for this endpoint study record was obtained from an experimental study. The OECD GLP criteria were met and the methods applied are fully compliant with OECD TG 471.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- (4-butoxy-2,3-difluorophenyl)boronic acid
- EC Number:
- 692-793-0
- Cas Number:
- 156487-12-6
- Molecular formula:
- C10H13BF2O2
- IUPAC Name:
- (4-butoxy-2,3-difluorophenyl)boronic acid
- Test material form:
- solid
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9: rat liver homogenate from male Wistar rats, Crl: WI (HAN) (Charles River, Germany), aged 6 - 8 weeks that were pretreated with ß-Naphthoflavone (100 mg/kg body weight) and Phenobarbital (80 mg/kg body weight).
- method of preparation of S9 mix: livers removed and homogenized in ice-cold 0.15 M KCl (3 mL
KCl per g liver wet-weight). The homogenate was spun for 10 minutes at 9000 rpm (8784 x g, Biofuge 28 RS) and +4°C. The supernatant fluid (S9) was decanted, transferred to sterile tubes and stored in liquid nitrogen.
- concentration or volume of S9 mix and S9 in the final culture medium: 10 % and 20 % S9 in the S9 mix were used in the 1st and 2nd test series; 0.5 mL were used in the final culture medium
- quality controls of S9: Each S9 batch was tested for its metabolic activity using specific substrates. - Test concentrations with justification for top dose:
- 5, 15.8, 50, 158, 500, 1580, 5000 μg/plate ± S9 mix
- Vehicle / solvent:
- - Vehicle used: DMSO
DMSO was selected as solvent for the current experiment and 5000 µg/plate was chosen as the appropriate maximum test concentration.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other:
- Remarks:
- 20 μg/plate (TA98); 60 μg/plate (TA 1537) without S9 mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- 2 μg/plate (WP2 uvrA) without S9 mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- 2 μg/plate (TA 100, TA 1535) without S9 mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other:
- Remarks:
- 2 µg/plate (TA98, TA 100); 5 μg/plate (TA1535, TA 1537); 10 μg/plate (WP2 uvrA) with S9 mix
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: triplicate
- Number of independent experiments: 2
METHOD OF TREATMENT/ EXPOSURE:
- Test substance in agar (plate incorporation)
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 48 hours
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: background growth inhibition - Evaluation criteria:
- A test material was to be defined as positive or mutagenic in this assay if
- the assay is considered valid and
- a biologically relevant increase in the mean number of revertants above a threshold of 2-fold (TA 98,
TA 100, WP2 uvrA) or 3-fold (TA 1535, TA 1537) as compared to the concurrent negative controls is
observed
- an increase exceeding the threshold at only one concentration is considered as biologically
meaningful if reproduced in a second independent experiment
- a concentration-dependent increase is considered biologically meaningful if the threshold is exce
eded at more than one concentration
A test material is defined as negative or non-mutagenic in this assay if
- the assay is considered valid and
- none of the above-mentioned criteria are met
Whenever colony counts remain within the historical range of negative controls, such increases are considered as biologically not meaningful. In general, two series of experiments must be performed.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Solvent and positive control treatments were included for all strains. The mean numbers of revertant colonies were all within acceptable ranges for solvent control treatments, or were clearly elevanted by positive control treatments, thus, showing the expected reversion properties of all strains and good metabolic activity of the S9 mix used.
Following treatment of all bacteria tester strains with the test substance in the absence and presence of S9 mix, no relevant increases in revertant numbers were observed.
According to the criteria for negative and positive results predetermined in the study plan, the test substance was not mutagenic under the described experimental conditions.
Any other information on results incl. tables
1st Series
Metabolic Activation | Test Material | Concentr. [µg/plate] |
| Revertants per plate (Mean ± SD) | ||||
|
|
|
|
|
|
|
|
|
|
|
|
| TA 98 | TA 100 | TA 1535 | TA 1537 | WP2 uvrA |
|
|
|
|
|
|
|
|
|
Without Activation | DMSO |
|
| 34 ± 12 | 123 ± 7 | 16 ± 7 | 10 ± 3 | 27 ± 4 |
Test item | 5.00 |
| 40 ± 2 | 117 ± 3 | 21 ± 1 | 9 ± 5 | 24 ± 5 | |
| 15.8 |
| 38 ± 6 | 107 ± 26 | 17 ± 10 | 9 ± 3 | 28 ± 9 | |
| 50.0 |
| 29 ± 8 | 106 ± 8 | 20 ± 6 | 10 ± 2 | 32 ± 3 | |
| 158 |
| 37 ± 5 | 124 ± 13 | 12 ± 2 | 10 ± 6 | 29 ± 6 | |
| 500 |
| 30 ± 4B | 112 ± 10B | 18 ± 8B | 7 ± 2B | 33 ± 2B | |
| 1580 |
| 35 ± 7E | 116 ± 12T E | 11 ± 3T E | 1 ± 1T E | 32 ± 8E | |
| 5000 |
| 37 ± 7E | 90 ± 17T E | 12 ± 5T E | 0 ± 0T E | 34 ± 8E | |
DAUN | 2.00 |
| 397 ± 39 |
|
|
|
| |
NaN3 | 2.00 |
|
| 1525 ± 75 | 668 ± 71 |
|
| |
9-AA | 50.0 |
|
|
|
| 1380 ± 541 |
| |
NQO | 2.00 |
|
|
|
|
| 1558 ± 159 | |
|
|
|
|
|
|
|
|
|
With Activation | DMSO |
|
| 36 ± 11 | 125 ± 10 | 13 ± 4 | 10 ± 5 | 32 ± 5 |
Test item | 5.00 |
| 31 ± 6 | 125 ± 12 | 9 ± 3 | 9 ± 3 | 42 ± 5 | |
| 15.8 |
| 36 ± 6 | 126 ± 13 | 13 ± 1 | 11 ± 3 | 41 ± 6 | |
| 50.0 |
| 36 ± 6 | 112 ± 3 | 16 ± 6 | 7 ± 4 | 36 ± 4 | |
| 158 |
| 33 ± 6 | 147 ± 11 | 11 ± 5 | 12 ± 0 | 31 ± 2 | |
| 500 |
| 36 ± 1B | 151 ± 5B | 13 ± 1B | 7 ± 2B | 32 ± 1B | |
| 1580 |
| 37 ± 4E | 147 ± 13T E | 5 ± 4T E | 1 ± 1T E | 30 ± 4E | |
| 5000 |
| 37 ± 8E | 117 ± 12T E | 10 ± 2T E | 1 ± 1T E | 28 ± 10E | |
2-AA | 2.00 |
| 1120 ± 162 | 2099 ± 137 |
|
|
| |
2-AA | 5.00 |
|
|
| 105 ± 2 | 291 ± 21 |
| |
2-AA | 10.0 |
|
|
|
|
| 303 ± 59 | |
|
|
|
|
|
|
|
|
|
2nd Series
Metabolic Activation | Test Material | Concentr. [µg/plate] |
| Revertants per plate (Mean ± SD) | ||||
|
|
|
|
|
|
|
|
|
|
|
|
| TA 98 | TA 100 | TA 1535 | TA 1537 | WP2 uvrA |
|
|
|
|
|
|
|
|
|
Without Activation | DMSO |
|
| 29 ± 6 | 123 ± 11 | 22 ± 5 | 8 ± 4 | 33 ± 7 |
Test item | 15.8 |
| - | - | - | 7 ± 5 | - | |
| 50.0 |
| 33 ± 9 | 123 ± 9 | 23 ± 7 | 12 ± 4 | 35 ± 6 | |
| 158 |
| 26 ± 10 | 131 ± 2 | 23 ± 7 | 7 ± 4 | 34 ± 6 | |
| 500 |
| 31 ± 12B | 130 ± 14B | 19 ± 3B | 8 ± 2B | 33 ± 4B | |
| 1580 |
| 24 ± 6T E | 74 ± 19T E | 12 ± 4T E | 2 ± 1T E | 35 ± 2E | |
| 5000 |
| 22 ± 3T E | 40 ± 64T E | 11 ± 5T E | 2 ± 1T E | 33 ± 1E | |
DAUN | 2.00 |
| 223 ± 81 |
|
|
|
| |
NaN3 | 2.00 |
|
| 1333 ± 43 | 760 ± 28 |
|
| |
9-AA | 50.0 |
|
|
|
| 538 ± 228 |
| |
NQO | 2.00 |
|
|
|
|
| 1742 ± 116 | |
|
|
|
|
|
|
|
|
|
With Activation | DMSO |
|
| 35 ± 4 | 128 ± 21 | 17 ± 3 | 14 ± 7 | 38 ± 6 |
Test item | 15.8 |
| - | - | - | 12 ± 5 | - | |
| 50.0 |
| 35 ± 2 | 130 ± 17 | 15 ± 3 | 13 ± 1 | 40 ± 17 | |
| 158 |
| 36 ± 12 | 128 ± 10 | 14 ± 5 | 8 ± 5 | 41 ± 5 | |
| 500 |
| 35 ± 5B | 140 ± 19B | 17 ± 4B | 10 ± 6B | 38 ± 8B | |
| 1580 |
| 31 ± 7T E | 101 ± 27T E | 13 ± 2T E | 5 ± 3T E | 36 ± 2E | |
| 5000 |
| 26 ± 11T E | 46 ± 32T E | 9 ± 2T E | 1 ± 1T E | 33 ± 5E | |
2-AA | 2.00 |
| 231 ± 18 | 492 ± 105 |
|
|
| |
2-AA | 5.00 |
|
|
| 89 ± 6 | 135 ± 3 |
| |
2-AA | 10.0 |
|
|
|
|
| 176 ± 12 | |
|
|
|
|
|
|
|
|
|
Key to Positive controls | Key to Plate Postfix Codes | ||||||||||||||
|
|
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions reported here, the test item did not induce gene mutations by base-pair or frameshift changes in the genome of the strains used. Therefore, it was concluded that with and without addition of S9 mix as the exogenous metabolizing System, the test item was not mutagenic in this Salmonella typhimurhim and Escherichia coli reverse mutation test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.